EvoStem

Evostem is an Italian biotechnology company specializing in the development of innovative therapies derived from the secretome of mesenchymal stem cells (MSCs). The company focuses on the isolation and characterization of extracellular vesicles (EVs), also known as exosomes, to harness their regenerative and anti-inflammatory properties for medical and aesthetic applications. Evostem's proprietary platform aims to provide cell-free therapeutic solutions that overcome the logistical and safety challenges associated with traditional live cell therapies. Their primary research areas include dermatology, wound healing, and musculoskeletal disorders such as osteoarthritis. By leveraging advanced bioprocessing techniques, Evostem seeks to deliver standardized, high-potency EV-based products for the regenerative medicine market.